YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
[mrna Cancer Vaccine] wildpixel/iStock via Getty Images INVESTORS SHOULD KNOW: Personalized mRNA cancer vaccines are moving beyond their first major clinical success in melanoma into a broader test across harder-to-treat solid tumors. The…
Twist Bioscience has seen its assessed fair value move from US$105.30 to US$109.58, a modest reset that feeds into how analysts frame the stock's price targets. The shift comes as research coverage splits between those pointing to higher p…
Twist Bioscience has turned into one of the market's stronger long term performers, and the latest surge leaves a simple but important question on the table. Do the company's current cash flows and their future potential really support tod…
Equity Insider News Commentary AUSTIN, Texas, Oct. 1, 2026 /PRNewswire/ -- Towards Healthcare projects that the global AI in drug discovery market will grow from $19.89 billion in 2025 to $160.49 billion by 2035, a compound annual growth r…
Oracle Corporation (NYSE:ORCL) continues to insist that its massive 2.5-gigawatt AI data center campus, known as Project Jupiter, remains on schedule. However, concerns surrounding power availability, permitting, and construction have rais…
Cathie Wood’s Ark Invest boosted its technology, biotechnology, and space exposure last week, led by purchases of more than 51K shares of Meta Platforms (META [https://seekingalpha.com/symbol/META]) worth $38.2M and roughly 360K shares of…
Alphabet Inc. (NASDAQ:GOOGL) is approaching another important milestone in its artificial intelligence push. On September 23, Google DeepMind division head Koray Kavukcuoglu confirmed that the company is nearing the launch of Gemini 4. The…
Eli Lilly and Company (NYSE:LLY) received a modest price target raise on September 18 from Guggenheim. The brokerage increased its target to $1,284 from $1,273 while maintaining a Buy rating on the pharma stock. But perhaps the more import…
[Ozempic Insulin injection pen] CR/iStock via Getty Images INVESTORS SHOULD KNOW: The obesity drug market is undergoing a structural shift, moving beyond the initial injectable GLP-1 franchise. Now, the industry is moving toward a broader…
Intuit Inc. (NASDAQ:INTU) used its Investor Day to reinforce its long-term growth strategy rather than introduce a major change to its financial outlook. On September 18, UBS reiterated its Neutral rating and $360 price target following th…
Twist Bioscience Corporation (NASDAQ:TWST) is on the cusp of gaining significant exposure to the rapidly evolving artificial intelligence (AI)-driven drug discovery ecosystem. On September 16, the company confirmed a strategic partnership…
Bullish - green stock market chart with arrow up day trade by Quality Stock Arts via Shutterstock Twist Bioscience (TWST) has surged 493% over 52 weeks, maintaining strong technical momentum. Shares just hit a new all-time high and has a 1…
Company Logo DNA Synthesis Market Accelerates on Precision Medicine, Synthetic Biology and High-Throughput Automation Demand Dublin, Sept. 18, 2026 (GLOBE NEWSWIRE) -- "DNA Synthesis Market Opportunity, Growth Drivers, Industry Trend Analy…
On 16 September 2026, Twist Bioscience announced an agreement with Lilly TuneLab, under which Twist will provide antibody characterization data services using preferred Twist protocols to generate high-quality wet lab data that feed Lilly'…
Healthcare stocks were slightly lower late Wednesday afternoon, with the NYSE Healthcare Index fract PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
[Two coloured ropes knotted together] Richard Drury Twist Bioscience (TWST [https://seekingalpha.com/symbol/TWST]) and Ginkgo Bioworks (DNA [https://seekingalpha.com/symbol/DNA]) traded higher on Wednesday after announcing agreements with…
Parnassus Investments, an investment management company, released the "Parnassus Growth Equity Fund" second-quarter 2026 investor letter. The letter can be downloaded here. During the quarter, the Fund (Investor Shares) returned 17.49% (ne…
Healthcare stocks were edging higher pre-bell Wednesday, with the State Street Health Care Select Se PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Antibody characterization data generated by Twist supports TuneLab AI models designed to accelerate antibody discovery SOUTH SAN FRANCISCO, Calif., September 16, 2026--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap…
This article first appeared on GuruFocus. Cathie Wood's Ark Invest made a sharp rotation across technology and biotechnology stocks last week, buying roughly $28 million of Meta Platforms (NASDAQ:META) while selling a nearly identical doll…
Cathie Wood, head of Ark Investment Management, often buys her favorite tech stocks when she sees a new opportunity. That's what she did last week, pouring $27.9 million into Meta Platforms (META) as the company pushes deeper into AI. Last…
Cathie Wood, chief of Ark Investment Management, likes to chase momentum in her favorite tech bets. This week, she's buying $6.5 million of Cerebras stock as the AI chip stock surges. Last year, the flagship Ark Innovation ETF gained 35.49…
SOUTH SAN FRANCISCO, Calif., September 09, 2026--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscienc…
Artisan Partners, an investment management company, released its second-quarter 2026 investor letter for the "Artisan Mid Cap Fund". The letter can be downloaded here. Global equities rebounded sharply in Q2 2026, recovering from March low…
[Bitcoin 2022 Conference Draws Cryptocurrency Industry Professionals And Investors To Miami] Marco Bello/Getty Images News Cathie Wood’s Ark Invest leaned further into high-growth themes, including space, fintech, crypto, and biotechnology…
AUSTIN, Texas, Sept. 3, 2026 /PRNewswire/ -- Equity Insider News Commentary - Pharmaceutical research is being rebuilt around artificial intelligence faster than the industry can absorb it. Arizton values the global AI in drug discovery ma…
[short sale] abluecup As September begins, investors are keeping a close eye on heavily shorted stocks that could see heightened volatility. The latest mid- to mega-cap screen shows 44 stocks with short interest above 20% of shares outstan…
This article first appeared on GuruFocus. Cathie Wood's Ark (ARK) Invest made a sharp semiconductor rotation last week, adding roughly $53 million of Nvidia (NASDAQ:NVDA) and $41 million of Broadcom (NASDAQ:AVGO) while selling about $95 mi…
Cathie Wood, chief of Ark Investment Management, often uses post-earnings swings to add to her favorite tech stocks. This week, she's buying more Nvidia, adding $53 million to her stake as the stock pulled back a day after surging on bette…
Cathie Wood is known to double down on volatile technology stocks when others start backing away. This week, she's loading up on Cerebras Systems (CBRS), the newest publicly traded AI chip company that's looking to challenge Nvidia (NVDA).…
[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images As the month of August 2026 comes to a close, the broader stock market has exhibited a mix of late-summer consolidati…
Cathie Wood, chief of Ark Investment Management, often trims her biggest winners after sharp rallies. This week, she's selling Tempus AI (TEM), taking some shares off the table after the healthcare AI stock surged nearly 30% in days and be…
[mRNA or messenger RNA. The concept of mRNA vaccine. Innovative methods to treat virus. 3d render] Krot Studio INVESTORS SHOULD KNOW: A major Phase 3 trial win from Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) and Merck (MRK [http…
Wall Street’s major averages closed firmly higher on Friday, with Treasury yields largely steady and Bitcoin experiencing sharp intraday swings. The Dow Jones Industrial Average advanced 0.9%, the S&P 500 rose 0.4%, and the Nasdaq Composit…
Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index rising 3.1% a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
[US 100 dollar bill folded into an up arrow on wooden table. Illustration of the concept of inflation, profit, earning and investment] Biotech stocks have reached their highest level since the height of the pandemic after Moderna (MRNA [ht…